CITADEL ADVISORS LLC

Position in BLRX — BioLineRx Ltd.

CIK 1423053 MIAMI, FL

Back to BLRX Full portfolio

Position in BLRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$46,163

-$55,360 QoQ

Shares Held

14,796

-59.6% QoQ

Ownership

0.339%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 14 holders

Holding Since

Dec 2020

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in BLRX Over Time

Shares Held

Position Value (USD)

Derivatives in BLRX

reported options exposure · as of Dec 31, 2025

CallValue

$32,132

CallShares

11,600

PutValue

$33,240

PutShares

12,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,086,778,995 across 435 Biotechnology names. BLRX ranks #388 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ONC	BeOne Medicines Ltd.	1,425,517	$406,229,578
2	BBIO	BridgeBio Pharma, Inc.	3,760,028	$280,046,885
3	INSM	INSMED Inc	2,556,973	$272,624,460
4	MDGL	Madrigal Pharmaceuticals, Inc.	507,233	$272,358,759
5	VRTX	Vertex Pharmaceuticals Inc / Ma	510,430	$253,545,893
6	JAZZ	Jazz Pharmaceuticals plc	1,006,676	$242,578,715
7	MANE	Veradermics, Inc	1,877,775	$230,853,658
8	ROIV	Roivant Sciences Ltd.	5,576,261	$197,343,876

All Filings in BLRX

Export CSV

37 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$46,163	14,796	-59.6%	Shares	Defined	2026-08-14
2025-12-31	$101,523	36,651	+265.8%	Shares	Defined	2026-02-17
2025-12-31	$33,240	12,000	-1.6%	Put	Defined	2026-02-17
2025-12-31	$32,132	11,600	-73.3%	Call	Defined	2026-02-17
2025-09-30	$37,875	10,020	-33.0%	Shares	Defined	2025-11-14
2025-06-30	$198,795	43,500	-42.1%	Call	Defined	2025-08-14
2025-06-30	$55,754	12,200	+139.2%	Put	Defined	2025-08-14
2025-06-30	$68,339	14,954	-2.4%	Shares	Defined	2025-08-14
2024-12-31	$1,071	5,100	-19.0%	Put	Defined	2025-02-14
2024-12-31	$15,771	75,100	+61.5%	Call	Defined	2025-02-14
2024-12-31	$3,215	15,314	-36.8%	Shares	Defined	2025-02-14
2024-09-30	$25,110	46,500	-6.8%	Call	Defined	2024-11-14
2024-09-30	$3,402	6,300	-43.8%	Put	Defined	2024-11-14
2024-06-30	$28,443	49,900	+107.1%	Call	Defined	2024-08-14
2024-06-30	$6,384	11,200	-8.2%	Put	Defined	2024-08-14
2024-03-31	$26,992	24,100	-33.8%	Call	Defined	2024-05-15
2024-03-31	$13,664	12,200	+177.3%	Put	Defined	2024-05-15
2023-12-31	$38,017	24,215	-58.9%	Shares	Defined	2024-02-14
2023-12-31	$57,148	36,400	-63.3%	Call	Defined	2024-02-14
2023-12-31	$6,908	4,400	+4.8%	Put	Defined	2024-02-14
2023-09-30	$7,644	4,200	+4100.0%	Put	Defined	2023-11-14
2023-09-30	$180,362	99,100	+121.2%	Call	Defined	2023-11-14
2023-09-30	$107,296	58,954	-72.3%	Shares	Defined	2023-11-14
2023-06-30	$340,430	212,769	+834.3%	Shares	Defined	2023-08-14
2023-06-30	$71,680	44,800	+335.0%	Call	Defined	2023-08-14
2023-06-30	$160	100	-99.6%	Put	Defined	2023-08-14
2022-06-30	$29,150	22,774	-86.2%	Shares	Defined	2022-08-15
2022-06-30	$13,184	10,300	-6.4%	Call	Defined	2022-08-15
2022-03-31	$18,810	11,000	-47.9%	Call	Defined	2022-05-16
2021-12-31	$48,348	23,700	-71.3%	Put	Defined	2022-02-14
2021-12-31	$43,044	21,100	-23.3%	Call	Defined	2022-02-14
2021-09-30	$454,162	165,150	+266.2%	Shares	Defined	2021-11-15
2021-09-30	$227,150	82,600	+154.9%	Put	Defined	2021-11-15
2021-06-30	$126,722	45,097	-8.5%	Shares	Defined	2021-08-16
2021-06-30	$77,275	27,500	—	Call	Defined	2021-08-16
2021-06-30	$91,044	32,400	—	Put	Defined	2021-08-16
2020-12-31	$124,238	49,301	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.